GlassScriptPhysician profile
Gabrielle Henriksen
NPI 1780061689
$3,190.42
in general payments reported to CMS, 2019-2025
38 companies · $20.17 in 2025
The $20.17 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $492 · 2020: $95.91 · 2021: $151 · 2022: $923 · 2023: $670 · 2024: $839 · 2025: $20.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,528.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $385.97 | 2022-2024 | Qulipta |
| Merck Sharp & Dohme LLC | $230.06 | 2021-2024 | Verquvo, Belsomra, Steglatro |
| Astrazeneca Pharmaceuticals LP | $224.00 | 2022-2024 | Airsupra, Farxiga, Breztri |
| Janssen Pharmaceuticals, INC | $196.44 | 2022-2023 | Xarelto |
| Exact Sciences Corporation | $183.83 | 2023-2024 | Cologuard Collection Kit |
| Novo Nordisk INC | $178.36 | 2019-2024 | Rybelsus, Ozempic |
| Glaxosmithkline, LLC. | $172.22 | 2019-2024 | Trelegy Ellipta, Arexvy |
| Amgen INC. | $155.85 | 2019-2022 | |
| Lilly USA, LLC | $155.84 | 2019-2023 | Mounjaro |
| Esperion Therapeutics, INC. | $143.54 | 2021-2024 | Nexletol |
| Boston Scientific Corporation | $125.00 | 2023 | Watchman Access System |
| Otsuka America Pharmaceutical, INC. | $113.32 | 2022-2024 | Rexulti, Nuedexta |
| Daiichi Sankyo INC. | $105.70 | 2019-2024 | Injectafer |
| Abbott Laboratories | $83.32 | 2019-2025 | Freestyle Libre 3, Proclaim |
| Medtronic, INC. | $72.08 | 2022 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gabrielle Henriksen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.